Skip to main content
BMJ Open logoLink to BMJ Open
. 2015 Aug 3;5(8):e005836corr1. doi: 10.1136/bmjopen-2014-005836corr1

Correction

PMCID: PMC4539391  PMID: 26243550

Dunlop SM, Dobbins T, Young JM, et al. Impact of Australia's introduction of tobacco plain packs on adult smokers' pack-related perceptions and responses: results from a continuous tracking survey. BMJ Open 2014;4:e005836.

An error in coding resulted in 428 ineligible cases being included in this study. These ineligible cases were part of a concurrent pilot study of recruitment via mobile phone. The coding error was applied to the descriptive statistics and regression analyses, but not the time-series analyses. The correction of this error does not change the results or conclusions of the study, but for clarification, the following corrections are noted:

1. The sample size in the ‘Participants’ section of the Abstract should be 15 375.

2. In the Method section, ‘Analyses for this study are limited to smokers interviewed between April 2006 and May 2013 (total n=15 745)’ should read ‘Analyses for this study are limited to smokers interviewed between April 2006 and May 2013 (total n=15 375)’.

3. In the Results section, ‘the increase in cognitive and emotional responses occurred after 3 months (cognitive: from 13% in September 2012 to 20% in January 2013; emotional: from 13% to 27%)’ should read ‘the increase in cognitive and emotional responses occurred after 3 months (cognitive: from 13% in September 2012 to 21% in January 2013; emotional: from 13% to 29%)’.

4. In the Results section, ‘Compared with the preplain packaging period (August/September 2012), scores on the scale were significantly higher in immediate postplain packaging period (December/January) and in the 5–6 month postplain packaging period (April/May). These effects were independent of any differences between the samples on sociodemographic or smoking characteristics, antismoking advertising activity, or increases in cigarette costliness’ should read ‘Compared with the preplain packaging period (August/September 2012), scores on the scale were significantly higher in immediate postplain packaging period (December/January). This effect was independent of any differences between the samples on sociodemographic or smoking characteristics, antismoking advertising activity, or increases in cigarette costliness’.

5. In the Results section, ‘says something good about them (from 27% to 76%), influences the brand they buy (from 27% to 77%), makes their brand stand out (from 22% to 78%), is fashionable (from 27% to 80%)’ should read ‘says something good about them (from 27% to 78%), influences the brand they buy (from 27% to 79%), makes their brand stand out (from 22% to 81%), is fashionable (from 27% to 82%)’.

Corrected versions of tables 1 and 3, figures 1–3, supplementary figures 1 and 2 are below. The corrected versions of the figures result in minor changes to estimates for some data points, with no change in overall patterns of the data.

Table 1.

Sample characteristics from the Cancer Institute's Tobacco Tracking Survey (CITTS) April 2006 to May 2013 (smokers only; n=15 375)

N Per cent
Sex
 Female 8126 50
 Male 7249 50
Age (years)
 18–29 2265 21
 30–55 8260 48
 55+ 4848 31
Socioeconomic status
 Low 6443 41
 Moderate 3951 27
 High 4808 33
Smoking frequency
 Daily 13659 88
 Weekly 917 6
 Less than weekly 799 6
Smoking
 Low 5871 41
 Moderate 5705 38
 High 3384 22
Quit attempts in past 12 months
 None 9189 60
 At least one 5975 40
Year
 2006 1600 10
 2007 2289 15
 2008 2094 13
 2009 2135 14
 2010 2146 14
 2011 2157 14
 2012 2126 13
 2013 828 5

Ns are unweighted, per cents are weighted for age, sex and regional residence.

Table 3.

Results from linear regression models predicting Graphic Health Warning Impact and Negative Pack Perceptions from month of interview in the plain packaging and comparison periods

Comparison period (2011–2012)
Plain packaging period (2012–2013)
M (SD) β 95% CI p Value
M (SD) β 95% CI p Value
GHW impact
 Month
  August/September NA 2.67 (0.93) Ref
  October/November 2.57 (0.90) Ref 2.75 (0.97) 0.01 −0.15 0.21 0.747
  December/January 2.62 (0.99) −0.01 −0.25 0.21 0.847 2.86 (1.18) 0.09 0.05 0.50 0.017
  February/March 2.77 (0.89) 0.10 −0.19 0.58 0.323 2.75 (1.17) 0.06 −0.11 0.41 0.262
  April/May 2.67 (0.96) −0.01 −0.52 0.48 0.930 2.79 (1.22) 0.03 −0.12 0.29 0.403
Negative pack perceptions
 Month
  August/September NA 3.95 (0.76) Ref
  October/November 4.03 (0.60) Ref 3.96 (0.75) 0.03 −0.45 1.10 0.412
  December/January 4.11 (0.64) 0.06 −0.43 1.46 0.286 4.47 (0.65) 0.25 2.52 4.06 <0.001
  February/March 4.08 (0.59) 0.03 −1.40 1.88 0.775 4.56 (0.63) 0.31 2.58 4.38 <0.001
  April/May 4.03 (0.69) 0.07 −1.61 2.80 0.598 4.67 (0.58) 0.34 3.82 5.20 <0.001

Models controlled for demographics (sex, age, SES), smoking characteristics (frequency and level of smoking, 12 m quitting history), antismoking advertising activity (TARPs) and recent increases in cigarette costliness (% increase in past 12 weeks); M's and SD's are unweighted.

β, Standardised coefficient; GHW, Graphic Health Warnings; M, mean (range 1–5); NA, not applicable; SES, socioeconomic status; TARP, Target Audience Rating Points.

Figure 1.

Figure 1

Monthly proportions of smokers strongly agreeing that: (A) the graphic warnings encourage me to stop smoking (cognitive response); (B) with the graphic warnings, each time I get a cigarette out I worry that I should not be smoking (emotional response); (C) they make me feel that I should hide or cover my packet from the view of others (avoidant response) and (D) the only thing I notice on my cigarette pack is the graphic warnings (warning salience).

Figure 2.

Figure 2

Monthly proportions of smokers strongly disagreeing that their cigarette pack is: (A) attractive; (B) says something good about me to other smokers; (C) influences the brand I buy; (D) makes my brand stand out from other brands; (E) is fashionable and (F) matches my style.

Figure 3.

Figure 3

Monthly mean score for Graphic Health Warning Impact and Negative Pack Perceptions.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES